Advertisement
News
Subscribe to MDT Magazine News

Drugging the Undruggable

April 3, 2011 8:37 pm | by Massachusetts Institute of Technology | Comments

A chemical "staple" creates mobile biological molecules with staying power.

IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment

April 3, 2011 8:32 pm | by IBM | Comments

Researchers from IBM and the Institute of Bioengineering and Nanotechnology discovered a nanomedicine breakthrough in which new types of polymers were shown to physically detect and destroy antibiotic-resistant bacteria and infectious diseases like Methicillin-resistant Staphylococcus...

TOPICS:

Major New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery

April 3, 2011 3:37 pm | by Bio-Medicine.Org | Comments

DETROIT, April 3, 2011 /- A major new study presented today at the yearly scientific meeting of the American College of Cardiology (ACC) in New Orleans shows conclusively that replacing defective aortic valves in elderly patients through non-invasive "catheterization" – rather than...

TOPICS:
Advertisement

Metabolic Syndrome May Increase Risk for Liver Cancer

April 3, 2011 1:32 pm | by AACR | Comments

Tweet • Metabolic syndrome a known risk factor for diabetes and heart disease • Incidence of liver cancer continues to rise in U.S. • Link found with the most common types of liver cancer. ORLANDO, Fla. - Scientists have confirmed that metabolic syndrome, a constellation of conditions...

TOPICS:

Avoiding or Controlling Diabetes May Reduce Cancer Risk and Mortality

April 3, 2011 1:32 pm | by AACR | Comments

Tweet • Diabetes linked to an 11 percent increased risk for cancer mortality in women; 17 percent increased risk in men. • Increased risk for colon, rectum and liver cancer in men and women. • Associations appear to be independent of other cancer risk factors. ORLANDO, Fla. - Results of...

TOPICS:

Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System

April 3, 2011 12:34 pm | by Bio-Medicine.Org | Comments

BASKING RIDGE, N.J., April 3, 2011 /- Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced today the primary results of the RADAR Phase 2b clinical trial of the company's lead product, the...

TOPICS:

AACR Opposes Proposed Cuts to Fiscal Year 2011 Budget

April 3, 2011 12:33 pm | by AACR | Comments

Tweet • Cuts affect our nation's health, economic growth and national competitiveness. • Proposed reduction in House would bring NIH back to fiscal year 2008 levels. • Former Congressman, AACR officer and scientist addressed media Sunday, April 3. ORLANDO, Fla. - The U.S. Congress will...

TOPICS:

Smoking Did Not Influence Breast Cancer Risk Among Obese Women

April 3, 2011 12:32 pm | by AACR | Comments

Tweet • Association found between smoking and breast cancer risk in non-obese women. • Results were similar regardless of how obesity was defined. ORLANDO, Fla. - Smoking increases the risk of breast cancer, but the risk differs by obesity status in postmenopausal women, according to data...

TOPICS:
Advertisement

Movea sees success with miniaturised 9-axis Inertial Measurement Unit

April 3, 2011 7:37 am | by I-Micronews | Comments

MotionPod provides a fast track motion sensing solution for customers in health and fitness, gaming, and sports applications.

ROHM launches 600V/20A SiC Schottky barrier diodes

April 3, 2011 7:37 am | by I-Micronews | Comments

ROHM Semiconductor of San Diego, CA (the US arm of system LSI, discrete components and module product maker ROHM Co Ltd of Kyoto, Japan) has launched the SCS1xxAGC series of silicon carbide (SiC) Schottky barrier diodes (SBD).

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 3, 2011 7:34 am | by Bio-Medicine.Org | Comments

NEW ORLEANS, April 3, 2011 /- A pooled analysis of the SPIRIT II, III, IV and COMPARE trials presented today further reinforces the positive clinical performance of Abbott's (NYSE: ABT ) market-leading XIENCE V ® Everolimus Eluting Coronary Stent System. As part of the analysis of...

TOPICS:

Boston Scientific IONâ„¢ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data

April 3, 2011 7:33 am | by Bio-Medicine.Org | Comments

NATICK, Mass. and NEW ORLEANS, April 3, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS clinical trial data, demonstrating differences in safety and efficacy outcomes favoring the...

TOPICS:

Study supports fixing heart valves without surgery

April 3, 2011 5:45 am | by MARILYNN MARCHIONE - AP Medical Writer - Associated Press | Comments

Many people with a bad aortic valve may soon be able to avoid open-heart surgery and have a new one placed through a tube in an artery instead.A study finds that survival after a year is about the same for either way of replacing the aortic valve, which is the main gate for blood leaving the...

Young black athletes with sickle cell trait might be susceptible to sudden death

April 3, 2011 12:37 am | by EurekAlert | Comments

(Minneapolis Heart Institute Foundation) The sickle cell trait could be a cause -- albeit rare -- of sudden death in young African-American competitive athletes, most commonly during football training, according to a scientific poster that will be presented at the American College...

TOPICS:

Scientists Identify KRAS Rearrangements in Metastatic Prostate Cancer

April 2, 2011 9:31 pm | by AACR | Comments

Tweet • Genetic information may allow doctors to determine cancer prognosis. • KRAS is a known “oncogene” that leads to cancer. ORLANDO, Fla. - Scientists have uncovered a genetic characteristic of metastatic prostate cancer that defines a rare sub-type of this disease. These findings are...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading